ECPI - MARK (IT)Aug 23, 20220 min readGetting Back to Work After A StrokeGetting back to work after a stroke-Stro. Download • 383KB
NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic...SINGAPORE, Jan. 12, 2022 /PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association (JAMDA)1. Alzheime